Skip to main content
. 2018 Nov 8;145(1):91ā€“93. doi: 10.1001/jamaoto.2018.2936

Table. Patient Demographics and Tumor Characteristics.

Variable Finding (Nā€‰=ā€‰55)a
Sex
Male 31 (56.4)
Female 24 (43.6)
Race
White 45 (81.8)
Black 3 (5.5)
Otherb 5 (9.1)
Unknown 2 (3.6)
Age, mean (SD), y 48.6 (17.9)
Age categories, y
<50 26 (47.3)
50-59 14 (25.5)
60-69 8 (14.5)
70-79 3 (5.5)
80-84 4 (7.3)
Year of diagnosis
2011 1 (1.8)
2012 13 (23.6)
2013 7 (12.7)
2014 17 (30.9)
2015 17 (30.9)
Primary site
Parotid gland 42 (76.4)
Submandibular gland 3 (5.5)
Major salivary gland, NOS 10 (18.2)
Primary surgery
No primary surgery 7 (12.7)
Local tumor excision 12 (21.8)
Less than total parotidectomy or less than total removal of major salivary gland 25 (45.5)
Total parotidectomy or total removal of major salivary gland 14 (25.5)
Radical parotidectomy or radical removal of major salivary gland 2 (3.6)
Unknown 1 (1.8)
Lymph node surgery
Lymph node biopsy 1 (1.8)
Neck dissection 34 (61.8)
None 20 (36.4)
Lymph node involvement
Negative lymph node 32 (58.2)
Positive lymph node 3 (5.5)
Unknown or lymph node not examined 20 (36.4)
Tumor size, mean (SD), cm 1.95 (1.01)
Tumor size categories, cm
ā‰¤2 31 (56.4)
>2-4 19 (34.5)
>4 1 (1.8)
Unknown 4 (7.3)
AJCC stage group
I 25 (45.5)
II 18 (32.7)
III 6 (10.9)
IVA 1 (1.8)
Unknown 5 (9.1)
T stage
T1 27 (49.1)
T2 19 (34.5)
T3 3 (5.5)
T4a 1 (1.8)
TX 5 (9.1)
N stage
N0 51 (92.7)
N1 3 (5.5)
NX 1 (1.8)
M stage
M0 55 (100)
M1 0 (0)
Grade
I, well differentiated 11 (20.0)
II, moderately differentiated 14 (25.5)
Unknown 30 (54.5)
Follow-up, mean (SD), mo 20.3 (14.9)
Alive at follow-up 55 (100)

Abbreviations: AJCC, American Joint Committee on Cancer; NOS, not otherwise specified.

a

Data are presented as number (percentage) of patients or cases unless otherwise indicated.

b

American Indian, Alaska Native, Asian, or Pacific Islander.